These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31357953)
1. Quantitative investigation of factors relevant to the T cell spot test for tuberculosis infection in active tuberculosis. Li K; Yang C; Jiang Z; Liu S; Liu J; Fan C; Li T; Dong X BMC Infect Dis; 2019 Jul; 19(1):673. PubMed ID: 31357953 [TBL] [Abstract][Full Text] [Related]
2. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Chee CB; KhinMar KW; Gan SH; Barkham TM; Pushparani M; Wang YT Am J Respir Crit Care Med; 2007 Feb; 175(3):282-7. PubMed ID: 17082492 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with differential T cell responses to antigens ESAT-6 and CFP-10 in pulmonary tuberculosis patients. Liu S; Wu M; A E; Wu S; Geng S; Li Z; Li M; Li L; Pang Y; Kang W; Tang S Medicine (Baltimore); 2021 Feb; 100(8):e24615. PubMed ID: 33663071 [TBL] [Abstract][Full Text] [Related]
4. Performance Evaluation of IGRA-ELISA and T-SPOT.TB for Diagnosing Tuberculosis Infection. Zhu M; Zhu Z; Yang J; Hu K Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414740 [TBL] [Abstract][Full Text] [Related]
5. Integrating systemic immune-inflammation index, fibrinogen, and T-SPOT.TB for precision distinction of active pulmonary tuberculosis in the era of mycobacterial disease research. Yu Z; Shang Z; Huang Q; Wen F; Patil S Front Microbiol; 2024; 15():1382665. PubMed ID: 38725688 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic Significance of Xuan WX; Lu TT; Wang Z; An YX; Zhang XJ Chin Med J (Engl); 2017 Apr; 130(7):811-816. PubMed ID: 28345545 [TBL] [Abstract][Full Text] [Related]
7. Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis. Chee CB; Barkham TM; Khinmar KW; Gan SH; Wang YT Eur J Clin Microbiol Infect Dis; 2009 Jun; 28(6):667-70. PubMed ID: 19020909 [TBL] [Abstract][Full Text] [Related]
8. Interferon gamma response to combinations 38 kDa/CFP-10, 38 kDa/MPT-64, ESAT-6/MPT-64 and ESAT-6/CFP-10, each related to a single recombinant protein of Mycobacterium tuberculosis in individuals from tuberculosis endemic areas. Tavares RC; Salgado J; Moreira VB; Ferreira MA; Mello FC; Leung JW; Fonseca Lde S; Spallek R; Singh M; Saad MH Microbiol Immunol; 2007; 51(3):289-96. PubMed ID: 17380048 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the characteristics of the enzyme-linked immunospot assay for diagnosis of active tuberculosis in China. Wang L; Yu Y; Chen W; Feng J; Wang J; Zhao H; Ma L; Yang B; Ma Y; Dang P Clin Vaccine Immunol; 2015 May; 22(5):510-5. PubMed ID: 25739918 [TBL] [Abstract][Full Text] [Related]
10. [Evolution of IGRA researches]. Ariga H; Harada N Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999 [TBL] [Abstract][Full Text] [Related]
11. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy. Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776 [TBL] [Abstract][Full Text] [Related]
13. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection. Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147 [TBL] [Abstract][Full Text] [Related]
14. Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection. Luo Y; Tang G; Lin Q; Mao L; Xue Y; Yuan X; Ouyang R; Wu S; Yu J; Zhou Y; Liu W; Hou H; Wang F; Sun Z J Infect; 2020 Jul; 81(1):81-89. PubMed ID: 32360883 [TBL] [Abstract][Full Text] [Related]
15. The Application of T.SPOT-TB Assay for Early Diagnosis of Active Tuberculosis in Chronic Kidney Disease Patients Receiving Immunosuppressive Treatment. Wang H; Wang S; Xu L; Mao Y J Invest Surg; 2020 Oct; 33(9):853-858. PubMed ID: 30917713 [No Abstract] [Full Text] [Related]
16. Using the TBAg/PHA ratio in the T-SPOT(®).TB assay to distinguish TB disease from LTBI in an endemic area. Wang F; Hou HY; Wu SJ; Zhu Q; Huang M; Yin B; Huang J; Pan YY; Mao L; Sun ZY Int J Tuberc Lung Dis; 2016 Apr; 20(4):487-93. PubMed ID: 26970158 [TBL] [Abstract][Full Text] [Related]
17. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730 [TBL] [Abstract][Full Text] [Related]
18. Relationship between T-SPOT.TB responses and numbers of circulating CD4+ T-cells in HIV infected patients with active tuberculosis. Cai R; Chen J; Guan L; Sun M; Sun Y; Shen Y; Zhang R; Liu L; Lu H Biosci Trends; 2014 Jun; 8(3):163-8. PubMed ID: 25030851 [TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of T-SPOT. TB assay in 1 084 tuberculosis suspects]. Liu H; Huang Y; Wang J; Ni R; Zhang Z; Guo X; Zhao X Zhonghua Jie He He Hu Xi Za Zhi; 2014 Mar; 37(3):192-6. PubMed ID: 24809710 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Values of Peripheral Blood T-Cell Spot Test for Tuberculosis (T-SPOT.TB) for Spinal Tuberculosis. Xu T; Lai Q; Qu N; Zhang B; Qi Q Surg Infect (Larchmt); 2023 Aug; 24(6):534-540. PubMed ID: 37437114 [No Abstract] [Full Text] [Related] [Next] [New Search]